secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADIAL PHARMACEUTICALS, INC. (ADIL)
CIK:        0001513525
Form:       8-K
Filed at:   2025-08-01T23:59:59+00:00
Accession:  0001213900-25-070671
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adial enters new ATM facility for up to $4.98M; terminates prior HCW Wainwright ATM
--------------------------------------------------------------------------------

- New ATM sales agreement with A.G.P./Alliance Global Partners for up to $4,983,000 of common stock.
- Sales agent commission of 3.0% of gross proceeds; expense reimbursement up to $50k initial plus quarterly fees.
- Prior ATM with H.C. Wainwright terminated July 31, 2025; had raised ~$4M net from 2.35M shares.
- Company not obligated to sell shares; sales may be suspended at any time.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1513525/000121390025070671/0001213900-25-070671-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1513525/000121390025070671/ea0251183-8k_adial.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-070671

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer